A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape

被引:181
作者
Douek, DC
Betts, MR
Brenchley, JM
Hill, BJ
Ambrozak, DR
Ngai, KL
Karandikar, NJ
Casazza, JP
Koup, RA
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NCI, Med Branch, Dept Expt Transplantat & Immunol, NIH, Bethesda, MD 20892 USA
[3] Northwestern Univ, Mega Bases Inc, Evanston, IL 60201 USA
[4] Univ Texas, SW Med Ctr, Dallas, TX 75390 USA
关键词
D O I
10.4049/jimmunol.168.6.3099
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Escape from the CD8(+) T cell response through epitope mutations can lead to loss of immune control of HIV replication. Theoretically, escape from CD8(+) T cell recognition is less likely when multiple TCRs target individual MHC/peptide complexes, thereby increasing the chance that amino acid changes in the epitope could be tolerated. We studied the CD8(+) T cell response to six immunodominant epitopes in five HIV-infected subjects using a novel approach combining peptide stimulation, cell surface cytokine capture, flow cytometric sorting, anchored RT-PCR, and real-time quantitative clonotypic TCR tracking. We found marked variability in the number of clonotypes targeting individual epitopes. One subject recognized a single epitope with six clonotypes, most of which were able to recognize and lyse cells expressing a major epitope variant that arose. Additionally, multiple clonotypes remained expanded during the course of infection, irrespective of epitope variant frequency. Thus, CD8(+) T cells comprising multiple TCR clonotypes may expand in vivo in response to individual epitopes, and may increase the ability of the response to recognize virus escape mutants.
引用
收藏
页码:3099 / 3104
页数:6
相关论文
共 34 条
[11]   The art of the probable: System control in the adaptive immune system [J].
Germain, RN .
SCIENCE, 2001, 293 (5528) :240-245
[12]   Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation [J].
Goulder, PJR ;
Sewell, AK ;
Lalloo, DG ;
Price, DA ;
Whelan, JA ;
Evans, J ;
Taylor, GP ;
Luzzi, G ;
Giangrande, P ;
Phillips, RE ;
McMichael, AJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (08) :1423-1433
[13]   Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children [J].
Goulder, PJR ;
Tang, YH ;
Brander, C ;
Betts, MR ;
Altfeld, M ;
Annamalai, K ;
Trocha, A ;
He, SQ ;
Rosenberg, ES ;
Ogg, G ;
O'Callaghan, CA ;
Kalams, SA ;
McKinney, RE ;
Mayer, K ;
Koup, RA ;
Pelton, SI ;
Burchett, SK ;
McIntosh, K ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1819-1831
[14]   Viral clearance without destruction of infected cells during acute HBV infection [J].
Guidotti, LG ;
Rochford, R ;
Chung, J ;
Shapiro, M ;
Purcell, R ;
Chisari, FV .
SCIENCE, 1999, 284 (5415) :825-829
[15]  
Haas G, 1996, J IMMUNOL, V157, P4212
[16]  
Harrer T, 1996, J IMMUNOL, V156, P2616
[17]   T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: Analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant [J].
Kalams, SA ;
Johnson, RP ;
Dynan, MJ ;
Hartman, KE ;
Harrer, T ;
Harrer, E ;
Trocha, AK ;
Blattner, WA ;
Buchbinder, SP ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1669-1679
[18]   LONGITUDINAL ANALYSIS OF T-CELL RECEPTOR (TCR) GENE USAGE BY HUMAN IMMUNODEFICIENCY VIRUS-1 ENVELOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE CLONES REVEALS A LIMITED TCR REPERTOIRE [J].
KALAMS, SA ;
JOHNSON, RP ;
TROCHA, AK ;
DYNAN, MJ ;
NGO, HS ;
DAQUILA, RT ;
KURNICK, JT ;
WALKER, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1261-1271
[19]   Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses [J].
Kelleher, AD ;
Long, C ;
Holmes, EC ;
Allen, RL ;
Wilson, J ;
Conlon, C ;
Workman, C ;
Shaunak, S ;
Olson, K ;
Goulder, P ;
Brander, C ;
Ogg, G ;
Sullivan, JS ;
Dyer, W ;
Jones, I ;
McMichael, AJ ;
Rowland-Jones, S ;
Phillips, RE .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (03) :375-385
[20]  
Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO